Comparative Study
[Amlodipine: pharmacokinetic and pharmacodynamic profile of a calcium antagonist with prolonged effect]
[Article in
German]
- PMID: 1531545
Item in Clipboard
Comparative Study
[Amlodipine: pharmacokinetic and pharmacodynamic profile of a calcium antagonist with prolonged effect]
[Article in
German]
Schweiz Rundsch Med Prax.
.
Abstract
Amlodipine is a new calcium antagonist of the 1.4-dihydropyridine group for treatment of hypertension and angina pectoris. Amlodipine is distinct from other calcium antagonists by its pharmacokinetic profile: slower onset of action with less acute vasodilatation associated side effects and a sustained antihypertensive and anti-anginal efficacy over 24 hours.
Similar articles
-
A review of amlodipine in myocardial ischaemia.Postgrad Med J. 1991;67 Suppl 5:S48-51. Postgrad Med J. 1991. PMID: 1839440 Review.
-
The efficacy of amlodipine in the management of ischaemic heart disease.Postgrad Med J. 1991;67 Suppl 3:S24-8. Postgrad Med J. 1991. PMID: 1836871 Review.
-
Nilvadipine: profile of a new calcium antagonist. An overview.J Cardiovasc Pharmacol. 1994;24 Suppl 2:S92-107. J Cardiovasc Pharmacol. 1994. PMID: 7898101 Review.
-
[Amlodipin (Norvasc). A new calcium antagonist with long half-life].Tidsskr Nor Laegeforen. 1991 Jun 20;111(16):1981-2. Tidsskr Nor Laegeforen. 1991. PMID: 1830978 Review. Norwegian. No abstract available.
-
Amlodipine: a once daily calcium antagonist.J Hum Hypertens. 1991 Aug;5 Suppl 1:49-54. J Hum Hypertens. 1991. PMID: 1834846 Review.